Bristol-Myers Squibb

Release Summary

Bristol-Myers Squibb and Moffitt Cancer Center Enter Into a Collaboration Agreement as Part of U.S. Immuno-Oncology Rare Population Malignancy Program

Bristol-Myers Squibb